Unknown

Dataset Information

0

N-Glycosylation regulates fibroblast growth factor receptor/EGL-15 activity in Caenorhabditis elegans in vivo.


ABSTRACT: The regulation of cell function by fibroblast growth factors (FGFs) classically occurs through a dual receptor system of a tyrosine kinase receptor (FGFR) and a heparan sulfate proteoglycan co-receptor. Mutations in some consensus N-glycosylation sites in human FGFR result in skeletal disorders and craniosynostosis syndromes, and biophysical studies in vitro suggest that N-glycosylation of FGFR alters ligand and heparan sulfate binding properties. The evolutionarily conserved FGFR signaling system of Caenorhabditis elegans has been used to assess the role of N-glycosylation in the regulation of FGFR signaling in vivo. The C. elegans FGF receptor, EGL-15, is N-glycosylated in vivo, and genetic substitution of specific consensus N-glycosylation sites leads to defects in the maintenance of fluid homeostasis and differentiation of sex muscles, both of which are phenotypes previously associated with hyperactive EGL-15 signaling. These phenotypes are suppressed by hypoactive mutations in EGL-15 downstream signaling components or activating mutations in the phosphatidylinositol 3-kinase pathway, respectively. The results show that N-glycans negatively regulate FGFR activity in vivo supporting the notion that mutation of N-glycosylation sites in human FGFR may lead to inappropriate activation of the receptor.

SUBMITTER: Polanska UM 

PROVIDER: S-EPMC2785143 | biostudies-other | 2009 Nov

REPOSITORIES: biostudies-other

altmetric image

Publications

N-Glycosylation regulates fibroblast growth factor receptor/EGL-15 activity in Caenorhabditis elegans in vivo.

Polanska Urszula M UM   Duchesne Laurence L   Harries Janet C JC   Fernig David G DG   Kinnunen Tarja K TK  

The Journal of biological chemistry 20091002 48


The regulation of cell function by fibroblast growth factors (FGFs) classically occurs through a dual receptor system of a tyrosine kinase receptor (FGFR) and a heparan sulfate proteoglycan co-receptor. Mutations in some consensus N-glycosylation sites in human FGFR result in skeletal disorders and craniosynostosis syndromes, and biophysical studies in vitro suggest that N-glycosylation of FGFR alters ligand and heparan sulfate binding properties. The evolutionarily conserved FGFR signaling syst  ...[more]

Similar Datasets

| S-EPMC99976 | biostudies-literature
| S-EPMC20105 | biostudies-literature
| S-EPMC3378332 | biostudies-literature
| S-EPMC3521710 | biostudies-literature
| S-EPMC6742027 | biostudies-literature
| S-EPMC3650002 | biostudies-literature
| S-EPMC4286680 | biostudies-literature
| S-EPMC7923394 | biostudies-literature
| S-EPMC3272044 | biostudies-literature
| S-EPMC8912769 | biostudies-literature